EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Dendritic Cell Vaccine Targeting CD70 for Osteosarcoma Lung Metastases

Pradeep Shrestha, Zhanglong Peng, Yuanzheng Yang, You Zhou, Eugenie S. Kleinerman

Cells · 17.11.2026 · 15 (22) · 2099

DOI: 10.3390/cells15222099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 17.11.2026. Verfasst von Pradeep Shrestha und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children’s Cancer Research Foundation, Frances Washburn Sarcoma Fund, The Mary V. and John A. Reilly Distinguished Chair to ESK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The overall survival for patients with relapsed metastatic osteosarcoma (OS) remains stagnant at

Förderung

  • Children’s Cancer Research Foundation
  • Frances Washburn Sarcoma Fund
  • The Mary V. and John A. Reilly Distinguished Chair to ESK

Zitieren

APA

Shrestha, P., Peng, Z., Yang, Y., Zhou, Y., & Kleinerman, E. S. (2026). A Novel Dendritic Cell Vaccine Targeting CD70 for Osteosarcoma Lung Metastases. Cells, 15(22), 2099. https://doi.org/10.3390/cells15222099

Vancouver

Shrestha P, Peng Z, Yang Y, Zhou Y, Kleinerman ES. A Novel Dendritic Cell Vaccine Targeting CD70 for Osteosarcoma Lung Metastases. Cells. 2026;15(22):2099. doi:10.3390/cells15222099

BibTeX
@article{Shrestha2026,
  author = {Shrestha, Pradeep and Peng, Zhanglong and Yang, Yuanzheng and Zhou, You and Kleinerman, Eugenie S.},
  title = {A Novel Dendritic Cell Vaccine Targeting CD70 for Osteosarcoma Lung Metastases},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {22},
  pages = {2099},
  doi = {10.3390/cells15222099}
}
Kostenlos starten →